Cross-resistance among nonnucleoside reverse transcriptase inhibitors limits recycling efavirenz after nevirapine failure

AIDS Research and Human Retroviruses

Volumn 18, Issue 12, 2002, Pages 835-838

  Antinori, Andrea ^a   Zaccarell, Mauro ^a   Cingolani, Antonella ^b   Forbici, Federica ^a   Rizzo, Maria G ^b   Trotta, Maria P ^a   Giambenedetto, Simona Di ^b   Narciso, Pasquale ^a   Ammassari, Adriana ^b   Girardi, Enrico ^a   De Luca, Andrea ^b   Perno, Carlo F ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EFAVIRENZ; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ANTIBIOTIC RESISTANCE; CONFERENCE PAPER; CONFIDENCE INTERVAL; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESPONSE; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; TREATMENT FAILURE; VIROLOGY;

DRUG RESISTANCE, MICROBIAL; HIV INFECTIONS; HIV-1; HUMANS; MUTATION; NEVIRAPINE; OXAZINES; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL;

EID: 0036376786     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/08892220260190308     Document Type: Article

References (8)

1. Clinical use of genotypic and phenotypic drug resistance testing to monitor antiretroviral chemotherapy
2. Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy
3. Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy
4. Incomplete genotypic resistance to nonnucleoside reverse transcriptase inhibitors in patients treated with nevirapine: A potential interest in clinical practice
5. Patterns of resistance mutations selected by treatment of human immunodeficiency virus type 1 infection with zidovudine, didanosine, and nevirapine
6. Non nucleoside reverse transcriptase inhibitor resistance
7. Non-nucleoside reverse transcriptase inhibitor resistance among patients failing a nevirapine plus protease inhibitor-containing regimen
8. Efavirenz- and adefovir dipivoxil-based salvage therapy in highly treatment-experienced patients: Clinical and genotypic predictors of virologic response